WMG Financial Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$463K Sell
3,605
-198
-5% -$23.2K 0.17% 56
2026
Q1
$457K Buy
3,803
+94
+3% +$10.9K 0.19% 52
2025
Q4
$390K Sell
3,709
-149
-4% -$14K 0.16% 72
2025
Q3
$324K Buy
3,858
+93
+2% +$7.66K 0.11% 133
2025
Q2
$298K Buy
3,765
+66
+2% +$5.25K 0.11% 132
2025
Q1
$332K Sell
3,699
-33
-0.9% -$3.08K 0.14% 102
2024
Q4
$371K Sell
3,732
-130
-3% -$13.4K 0.16% 93
2024
Q3
$439K Buy
3,862
+94
+2% +$11.2K 0.2% 75
2024
Q2
$467K Buy
3,768
+395
+12% +$50.9K 0.25% 64
2024
Q1
$445K Buy
+3,373
New +$416K 0.25% 68

Other funds holding MRK

WMG Financial Advisors's MRK Position: Q2 2026 in Review

WMG Financial Advisors reduced its Merck (MRK) stake by 5.2% in Q2 2026, selling an estimated $23.2K and leaving 3,605 shares worth $463K. The position accounts for 0.17% of the portfolio, ranked #56.

WMG Financial Advisors first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $467K in Q2 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • WMG Financial Advisors held 3,605 shares of Merck worth $463K as of Q2 2026.
  • WMG Financial Advisors sold 198 Merck shares in Q2 2026, an estimated $23.2K.
  • Merck made up 0.17% of WMG Financial Advisors's portfolio in Q2 2026, its #56 holding.
  • WMG Financial Advisors first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • WMG Financial Advisors's Merck position peaked at $467K in Q2 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on WMG Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.